Cite
HARVARD Citation
Holkova, B. et al. (n.d.). Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. Leukemia & lymphoma. 57 (3), pp. 635-643. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Holkova, B. et al. (n.d.). Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. Leukemia & lymphoma. 57 (3), pp. 635-643. [Online].